Table 7 Clinical phenotype study groups per GRADS
Clinical Phenotype Study Groups | n | % |
|---|---|---|
Group 1: Multiorgan | 16 | 8.6 |
Group 2: Nonacute, Stage I, untreated | 8 | 4.3 |
Group 3: Stage II-III, treated | 44 | 23.5 |
Group 4: Stage II-III, untreated | 23 | 12.3 |
Group 5: Stage IV, treated | 2 | 1.1 |
Group 6: Stage IV, untreated | 1 | 0.5 |
Group 7: Acute sarcoidosis | 4 | 2.1 |
Group 8: Remitting | 45 | 24.1 |
Group 9: Cardiac defining therapy | 7 | 3.7 |
Unclassifiable per GRADS | 37 | 19.8 |
 Stage 1, treated | 8 | 4.3 |
 Stage 0, treated | 27 | 14.4 |
 Stage 0, untreated | 2 | 1.1 |